Development and validation of a nomogram for assessing risk of isolated high 2-hour plasma glucose

A tool was constructed to assess need of an oral glucose tolerance test (OGTT) in patients whose fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) are normal. Data was collected from the longitudinal REACTION study conducted from June to November 2011 (14,686 subjects, aged ≥ 40 y). In people...

Full description

Bibliographic Details
Main Authors: Kan Sun, Xianchao Xiao, Lili You, Xiaosi Hong, Diaozhu Lin, Yujia Liu, Chulin Huang, Gang Wang, Feng Li, Chenglin Sun, Chaogang Chen, Jiahui Lu, Yiqin Qi, Chuan Wang, Yan Li, Mingtong Xu, Meng Ren, Chuan Yang, Guixia Wang, Li Yan
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.943750/full
_version_ 1818480307186171904
author Kan Sun
Xianchao Xiao
Lili You
Xiaosi Hong
Diaozhu Lin
Yujia Liu
Chulin Huang
Gang Wang
Feng Li
Chenglin Sun
Chaogang Chen
Jiahui Lu
Yiqin Qi
Chuan Wang
Yan Li
Mingtong Xu
Meng Ren
Chuan Yang
Guixia Wang
Li Yan
author_facet Kan Sun
Xianchao Xiao
Lili You
Xiaosi Hong
Diaozhu Lin
Yujia Liu
Chulin Huang
Gang Wang
Feng Li
Chenglin Sun
Chaogang Chen
Jiahui Lu
Yiqin Qi
Chuan Wang
Yan Li
Mingtong Xu
Meng Ren
Chuan Yang
Guixia Wang
Li Yan
author_sort Kan Sun
collection DOAJ
description A tool was constructed to assess need of an oral glucose tolerance test (OGTT) in patients whose fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) are normal. Data was collected from the longitudinal REACTION study conducted from June to November 2011 (14,686 subjects, aged ≥ 40 y). In people without a prior history of diabetes, isolated high 2-hour plasma glucose was defined as 2-hour plasma glucose ≥ 11.1 mmol/L, FPG < 7.0 mmol/L, and HbA1c < 6.5%. A predictive nomogram for high 2-hour plasma glucose was developed via stepwise logistic regression. Discrimination and calibration of the nomogram were evaluated by the area under the receiver operating characteristic curve (AUC) and Hosmer-Lemeshow test; performance was externally validated in Northeast China. Parameters in the model included gender, age, drinking status, marriage status, history of hypertension and hyperlipidemia, waist-to-hip ratio, FPG, and HbA1c. All variables were noninvasive, except FPG and HbA1c. The AUC of the nomogram for isolated high 2-hour plasma glucose was 0.759 (0.727-0.791) in the development dataset. The AUCs of the internal and externally validation datasets were 0.781 (0.712-0.833) and 0.803 (0.778-0.829), respectively. Application of the nomogram during the validation study showed good calibration, and the decision curve analysis indicated that the nomogram was clinically useful. This practical nomogram model may be a reliable screening tool to detect isolated high 2-hour plasma glucose for individualized assessment in patients with normal FPG and HbA1c. It should simplify clinical practice, and help clinicians in decision-making.
first_indexed 2024-12-10T11:21:44Z
format Article
id doaj.art-bbfc9e7c5787422a887c4cce5f01907c
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-12-10T11:21:44Z
publishDate 2022-09-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-bbfc9e7c5787422a887c4cce5f01907c2022-12-22T01:50:55ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-09-011310.3389/fendo.2022.943750943750Development and validation of a nomogram for assessing risk of isolated high 2-hour plasma glucoseKan Sun0Xianchao Xiao1Lili You2Xiaosi Hong3Diaozhu Lin4Yujia Liu5Chulin Huang6Gang Wang7Feng Li8Chenglin Sun9Chaogang Chen10Jiahui Lu11Yiqin Qi12Chuan Wang13Yan Li14Mingtong Xu15Meng Ren16Chuan Yang17Guixia Wang18Li Yan19Department of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, The First Hospital of Jilin University, Changchun, ChinaDepartment of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, The First Hospital of Jilin University, Changchun, ChinaDepartment of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, The First Hospital of Jilin University, Changchun, ChinaDepartment of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, The First Hospital of Jilin University, Changchun, ChinaDepartment of Clinical Nutrition, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Clinical Nutrition, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaDepartment of Endocrinology, The First Hospital of Jilin University, Changchun, ChinaDepartment of Endocrinology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, ChinaA tool was constructed to assess need of an oral glucose tolerance test (OGTT) in patients whose fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) are normal. Data was collected from the longitudinal REACTION study conducted from June to November 2011 (14,686 subjects, aged ≥ 40 y). In people without a prior history of diabetes, isolated high 2-hour plasma glucose was defined as 2-hour plasma glucose ≥ 11.1 mmol/L, FPG < 7.0 mmol/L, and HbA1c < 6.5%. A predictive nomogram for high 2-hour plasma glucose was developed via stepwise logistic regression. Discrimination and calibration of the nomogram were evaluated by the area under the receiver operating characteristic curve (AUC) and Hosmer-Lemeshow test; performance was externally validated in Northeast China. Parameters in the model included gender, age, drinking status, marriage status, history of hypertension and hyperlipidemia, waist-to-hip ratio, FPG, and HbA1c. All variables were noninvasive, except FPG and HbA1c. The AUC of the nomogram for isolated high 2-hour plasma glucose was 0.759 (0.727-0.791) in the development dataset. The AUCs of the internal and externally validation datasets were 0.781 (0.712-0.833) and 0.803 (0.778-0.829), respectively. Application of the nomogram during the validation study showed good calibration, and the decision curve analysis indicated that the nomogram was clinically useful. This practical nomogram model may be a reliable screening tool to detect isolated high 2-hour plasma glucose for individualized assessment in patients with normal FPG and HbA1c. It should simplify clinical practice, and help clinicians in decision-making.https://www.frontiersin.org/articles/10.3389/fendo.2022.943750/fulldiabetes mellitushyperglycemia2h OGTTnomogram modelrisk assessment model
spellingShingle Kan Sun
Xianchao Xiao
Lili You
Xiaosi Hong
Diaozhu Lin
Yujia Liu
Chulin Huang
Gang Wang
Feng Li
Chenglin Sun
Chaogang Chen
Jiahui Lu
Yiqin Qi
Chuan Wang
Yan Li
Mingtong Xu
Meng Ren
Chuan Yang
Guixia Wang
Li Yan
Development and validation of a nomogram for assessing risk of isolated high 2-hour plasma glucose
Frontiers in Endocrinology
diabetes mellitus
hyperglycemia
2h OGTT
nomogram model
risk assessment model
title Development and validation of a nomogram for assessing risk of isolated high 2-hour plasma glucose
title_full Development and validation of a nomogram for assessing risk of isolated high 2-hour plasma glucose
title_fullStr Development and validation of a nomogram for assessing risk of isolated high 2-hour plasma glucose
title_full_unstemmed Development and validation of a nomogram for assessing risk of isolated high 2-hour plasma glucose
title_short Development and validation of a nomogram for assessing risk of isolated high 2-hour plasma glucose
title_sort development and validation of a nomogram for assessing risk of isolated high 2 hour plasma glucose
topic diabetes mellitus
hyperglycemia
2h OGTT
nomogram model
risk assessment model
url https://www.frontiersin.org/articles/10.3389/fendo.2022.943750/full
work_keys_str_mv AT kansun developmentandvalidationofanomogramforassessingriskofisolatedhigh2hourplasmaglucose
AT xianchaoxiao developmentandvalidationofanomogramforassessingriskofisolatedhigh2hourplasmaglucose
AT liliyou developmentandvalidationofanomogramforassessingriskofisolatedhigh2hourplasmaglucose
AT xiaosihong developmentandvalidationofanomogramforassessingriskofisolatedhigh2hourplasmaglucose
AT diaozhulin developmentandvalidationofanomogramforassessingriskofisolatedhigh2hourplasmaglucose
AT yujialiu developmentandvalidationofanomogramforassessingriskofisolatedhigh2hourplasmaglucose
AT chulinhuang developmentandvalidationofanomogramforassessingriskofisolatedhigh2hourplasmaglucose
AT gangwang developmentandvalidationofanomogramforassessingriskofisolatedhigh2hourplasmaglucose
AT fengli developmentandvalidationofanomogramforassessingriskofisolatedhigh2hourplasmaglucose
AT chenglinsun developmentandvalidationofanomogramforassessingriskofisolatedhigh2hourplasmaglucose
AT chaogangchen developmentandvalidationofanomogramforassessingriskofisolatedhigh2hourplasmaglucose
AT jiahuilu developmentandvalidationofanomogramforassessingriskofisolatedhigh2hourplasmaglucose
AT yiqinqi developmentandvalidationofanomogramforassessingriskofisolatedhigh2hourplasmaglucose
AT chuanwang developmentandvalidationofanomogramforassessingriskofisolatedhigh2hourplasmaglucose
AT yanli developmentandvalidationofanomogramforassessingriskofisolatedhigh2hourplasmaglucose
AT mingtongxu developmentandvalidationofanomogramforassessingriskofisolatedhigh2hourplasmaglucose
AT mengren developmentandvalidationofanomogramforassessingriskofisolatedhigh2hourplasmaglucose
AT chuanyang developmentandvalidationofanomogramforassessingriskofisolatedhigh2hourplasmaglucose
AT guixiawang developmentandvalidationofanomogramforassessingriskofisolatedhigh2hourplasmaglucose
AT liyan developmentandvalidationofanomogramforassessingriskofisolatedhigh2hourplasmaglucose